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THE UNIVERSITY OF CHICAGO
THE LAW SCHOOL
I I I I EAST 60TH STREET
CHICAGO ILLINOIS 60637
Richard A. Epstein
James Parker Hall Distinguished
Service Professor of Law
August 2, 1991
Professor Rodney Smolla
Institute of Bill of Rights Law
Marshall-Wythe School of Law
The College of William and Mary
South Henry Street
Williamsburg, Virginia 23185
Re: Drug testing
Dear Rod:
I just received a copy of the proposal on drug testing and have some
comments to make on it and a small favor to ask.
Turning first to the Report, I think that it spends too much time of the
details of legislation without explaining why we need any legislation at all,
especially for private employers. I agree that drug testing is a hot and
sensitive issues. People do not like to be tested even if they are innocent, and
firms are uneasy about having workers who use drugs (or alcohol) on their
workforce, both for the safety and business risks that they could cause, and the
more diffuse reputational risks that go with trying to maintain a client base.
So clearly some balance has to be drawn.
The difficulty with your report is that it asks only one question, not
two. The question asked is the second in the sequence: what should be the
nature of the balance between firm and individual? The prior question is
whQ should make the balance? I find it a little ironic that a Bill of Rights
Institute, which should be dedicated to keeping government at bay
instinctively leaps to a legislative solution. Why not the contractual
solution? There are of course some problems with disclosure and variations
in terms, but skilled drafting can deal with those problems especially on an
institutional issue of such moment and import.
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One advantage of the contract solution is it does not require once-and-
for all balancing. Stated otherwise, there is an implicit assumption in your
report that all firms have roughly the same interest, and all workers have
roughly the same interests. But why should this be so, even within certain
categories of workers (e.g. high or low risk jobs). The best way in which to
find out the relative intensity of preferences (even legitimate preferences) is
to have them in bidding tension with each other. If an employer says that we
regard this as very important, then it has to be prepared to pay the price. It
will lose some workers who do not want to go through the testing, or it will
make accommodations on wages or other terms of employment. Some
employees will find the deal not to their liking, but they can seek out another
firm whose policies they find more congenial. There is a sorting equilibrium,
so that firms which want extensive testing get workers who are relatively
indifferent to the indignities involved. There is no reason to ask whether the
concern with drugs is "justified" with reference to the workplace. The
standards of relevance are defined internal to the workplace, and do not have
to be validated in any public forum. Likewise there is no need to figure out
what kinds of jobs call for random testing and which only allow it to be for
cause. There are private solutions that courts can enforce. There is no need
to convert intelligent hunches into binding law.
This position should help with drug enforcement. I suspect that the
balance on this issue in the marketplace is more toward testing than you
would like, but I don't think it is a bad thing. The standard enforcement of
drug policies is coercive. The state takes after those who seek to mind their
own business. Here the employer in effect waits until private individuals
come to it. Keeping off drugs now gets you something you want, and as the
incidence of drug use is reduced, the external benefits to the rest of us should
increase. Drug testing by employers can operate as a (relatively) efficient
substitute for public enforcement. Why then treat it with such deep suspicion
and concern?
There is a second element that needs a brief mention as well:
government employees. Does the fourth amendment have anything to do
with the types of drug tests that should be imposed. I think not. Here is a case
where consent by individual workers should be sufficient to validate the
consent. While I am a great fan of the unconstitutional conditions doctrine, I
don't think that it has any application where the government functions in
some sort of a competitive system, but should be reserved to those cases
where its monopoly position (with regulation or taxation) carries with it the
prospect of abuse. So in this regard I don't think that the public/private
distinction is of much moment, although it surely is in other areas.
Which gets me to my brief favor. You mention in your report that
there are lots of statutes that now work on the area. Is there any memo or
collection of materials that you have that I could see. I might want to include
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something on this question in a book on which I am working -."Bargaining
with the State" which is an expansion and revision of my Harvard Foreword
on Unconstitutional Conditions.
I am glad to see that you and your Institute are so active. Keep In
touch. And feel free to circulate this letter to your group if you think it is of
any interest or help.
Best regards,
Richard A. Epstein
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EISohly Laboratories, Incorporated
1215% Jaccson AvwnuoOxford, Missisppi 38M55
September 5, 1990
Dr. Paul Marcus
Professor of Law
College of Law
The University of Arizona
Tucson, AZ 85721
Dear Dr. Marcus:
This is in reference to your letter of August 16, 1990, in which you
requested that I provide you with a position paper regarding some of the
issues under consideration by the Task Force for the Drug Testing Project
of the Institute of Bill of Rights, College of William and Mary. It will
indeed be my pleasure and honor to provide you with the material you
requested.
Drug testing lsa valuable and effective tool in combatting drug abuse.
The ultimate goal of drug testing is to serve as a deterrent to
individuals who start out using drugs in a "recreational* fashion but who
might end up using them more and more to the point of addiction. Drug
testing also helps those individuals who are already having difficulty
abstaining on their own to come forward and seek professional help. When
carried out properly, drug testing is a valid means by which to identify
individuals who have used illicit drugs in the near past. Depending on
the drug to be identified, the individual's personal use habits, rate of
metabolism, and the test cutoff level, one could detect previous drug use
for periods of days or even weeks. What a single drug test will not do,
however, is identify whether the drug was used knowingly or unknowingly,
the method, or the exact time of use. This is particularly true when
urine is used as the biological specimen for analysis.
Laboratories involved in drug testing must operate in a strict forensic
manner, since in most cases the only evidence is the specimen submitted
for analysis. Maintaining proper chain of custody throughout the testing
process and proper documentation of the testing results are essential for
the validity of the test. Today, most drug testing laboratories,
especially those certified under the Department of Health and Human
Services (DHHS) guidelines, abide by these requirements and provide test
results which are both scientifically and legally defendable. Under the
guidelines, the testing process is delineated in such a way that specimens
must be tested at least two times using two independent aliquots from the
original bottle using two techniques operating by totally different
principles. One of these techniques (the confirmatory test) is mandated
to be gas chromatography/mass spectrometry (GC/HS) which is a very
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accurate "state of the art" test. Quality control procedures, both open
and blind, mandated within the laboratory, coupled with external quality
control carried out by the testing agency (also mandated under the
guidelines), provide necessary assurances to the accuracy of the testing
process. The continuous monitoring and evaluation of the laboratories'
performance through proficiency testing (six cycles per year) and on-site
inspections (twice a year by DHHS) provide added assurances to the
accuracy and reliability of the testing process. Testing for drugs of
abuse under DHHS guidelines is perhaps the most accurate and reliable
laboratory test one can get today.
I hope the information provided above gives you my position on the issue
of drug testing. In the meantime, should you need additional information,
need me to elaborate on any particular point, or discuss another area of
interest to the Task force, please let me know. I will be glad to get it
done immediately to meet your schedule.
With best regards, and good luck with your assignment.
Sincerely,
Mahmoud A./ISohly, Ph.D.
President
Laboratory Director
Attachment: CV
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OFFICE OF NATIONAL DRUG CONTROL POLICY
EXECUTIVE OFFICE OF THE PRESIDENT
Washington, D.C. 200
JUN 7 1990
Mr. Rodney A. Smolla
James Gould Cutler Professor
of Constitutional Law and
Director, Institute of Bill
of Rights Law
Marshall-Wythe School of Law
Williamsburg, Virginia 23185
Dear Mr. Smolla:
Drug testing performed with a high level of confidentiality
and accuracy, in conjunction with a drug-free workplace program,
has proven to be a deterrent to drug use by the casual user and
an impetus to seek help for the addict. Many companies use drug
testing to improve safety, to deter use, to improve productivity,
and to reduce health benefit costs.
The drug testing methodology certified by the National Institute
on Drug Abuse utilizes a urine specimen which measures the
existence of a drug, or its metabolized form. Although a urine
test does not indicate impairment level, a confirmed positive
test does indicate usage within days or weeks. This test uses an
immunoassay for the initial screen, and, if the results are
positive, a confirmation procedure is performed using GC/MS.
The level of accuracy for this technology and process is very
high; however a strong quality control process must be in
place to eliminate human errors.
If you would like additional information on the toxicological
methods or quality control procedures, please call the National
Institute on Drug Abuse workplace hotline at 1-800-845-4971.
Sincerely yours,
4 4
Herbert D. Kleber, M.D.
Deputy Director for
Demand Reduction
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THE CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOl
THE SOPHIE DAVIS SCHOOL OF BIOMEDICAL EDUCATION
THE CITY COLLEGE OF NEW YORK
DEPARTMENT OF PHARMACOLOGY (RM 19031
138th STREET & CONVENT AVENUE
NEW YORK. -NEW YORK 10031
September 11, 1990
Paul Marcus
Professor of Law
The University of Arizona
Tuscon, Arizona 85721
Dear Professor Marcus:
There is exactly one properly done study to ascertain whether
pre-employment testing to detect drug users sanitizes the
workplace. Dr. David Parish when asked to implement a testing
program for pre-employment applicants at an Atlanta Hospital
suggested a study of pre-employment testing instead. For six
months all applicants for work at the hospital were tested. All
qualified were hired whether they tested positive or negative. The
information about the test results were kept confidential. Most
of the positive group were positive for marijuana metabolite. All
employees were carefully evaluated one year after hiring as to
their suitability and work performance. There was no evaluation
differences between those testing positive and those testing
negative. More of the study group who tested negative had been
fired than those testing positive. I recently spoke with Dr.
Parish who told me that a year after his study, despite his
protests, pre-employment testing was instituted at the hospital
because management thought it best. This is, of course, a decision
to conduct a crusade rather than an evaluation of policy.
Urine testing of unimpaired workers for evidence of illicit
drug use has become widely accepted. When I entered the arguments
and controversies in 1983-1984, I would have characterized this
governmental and management-executed action as a data-free policy.
I would now in 1990 characterize testing as a data-proof policy.
Workplace-based drug testing has become less of a policy to be
evaluated than a crusade. Policies can be evaluated for what they
accomplish; crusades are evaluated by the degree of righteousness
we feel in conducting them. Those conducting the crusade produce
little or no credible evidence that the goals of drug testing are
being achieved. In fact, the statements indicating that drug
testing works as a policy were generated in 1984, and they are
simply repeated over and over in various forms today.
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Dr. Kieber's Letter
The accomplishments cited in this letter to Professor RA
Smolla in June of 1990 have a familiar ring:
"Drug testing.. .has proven to be a deterrent to drug use by
the casual user and an impetus to seek help for the addict.
Many companies use drug testing to improve safety, to deter
use, to improve productivity and to reduce health benefit
costs."
There are two things to say about the above quotes. How could
anyone oppose a policy which accomplished such things, and where
is the documentation proving that workplace testing would
accomplish them? The answer to the latter question is: nowhere.
I'll discuss briefly the technological dilemmas which remain but
more importantly, nowhere is there any proof at any acceptable
level that urine testing of apparently impaired workers:
1) has proven to be a deterrent to casual use,
2) forces addicted users to seek help,
3) improved productivity,
4) reduced health benefit costs,
5) augmented safety.
An Overview of Testing in 1990
What the testing does is fairly simple conceptually. If an
individual chosen for testing provides an authentic specimen, a
screening immunoassay followed by a confirmatbry GC-MS may identify
the reaction product (a metabolite) of an illegal drug. Recent
refinement of testing (and the narrowing of the searching) means
that it is rare for a false-positive test to occur. Most workplace
positives are secondary to the identification of delta-9-THC-
carboxy acid, a marijuana metabolite. In truth, the development
of the ability to detect extremely small amounts of marijuana
metabolite is the essence of the entire drug-testing enterprise.
The percent positive for illegal drugs in the Federal Workplace
tested heretofore is less than 1%. Most of these are secondary to
marijuana metabolite. The reported range of all positives due to
marijuana metabolite is 60-90%. Of the remaining drugs tested for
in the Federal programs (opiate, cocaine, amphetamine, and PCP)
opiate positives have essentially been withdrawn from
consideration. The end result of heroin metabolism in the urine
is morphine glucuronide. This is the same resultant if the testee
has consumed legal codeine or morphine or ingested poppy seeds or
poppy seed products. Although there is a test to assess a specific
heroin metabolite, this is not routinely done. Within the Federal
Program, if an individual tests positive for morphine metabolite,
he or she is simply exonerated by a Medical Review Officer if the
test is not confirmed by clinical evidence of opiate dependence.
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A positive test for PCP or amphetamine is rare. Although
there is some non-dependent or recreational use of cocaine by
Americans in the workplace, little is detected because the
metabolite persists for such a brief period of time and most users
consume off worktime and off premises.
The focus on marijuana should help us think about the other
claims of the benefits of testing. There is little evidence of
dysfunctional work caused by the occasional use of marijuana and
despite hyperbolic claims, there is little evidence that most users
of marijuana go on to particular trouble or heavy use. For
example, the most recent data of the High School Senior Survey,
confirms that use is conservative. Less than half of high school
seniors have ever tried marijuana. Of these who have ever tried,
only 38% have used in the last month, and 30% of those who have
ever tried have not used in the past year. Of those who have ever
tried, approximately six percent have smoked 20 of the last 30 days
and constitute regular users. Now if this is true, the rate of
dysfunctional drug use (mostly potential high dosage use of
marijuana) is very low in the workplace. Therefore, the current
testing simply detects at a high cost the use of marijuana and not
those in need of help and treatment.
The Firestone Study
Dr. Kleber's statement is very familiar. I have previously
written of the repeated use of a cadence of "facts" about the
workplace performance of drug users since 1984. These untruths
are repeated almost daily by those justifying a policy of testing
and they have been accepted as a true reflection of the workplace
drug problem. Dr. Sidney Cohen, supposedly quoting a study of the
Firestone Tire & Rubber Company generated this list.
The recreational drug user is:
4-5 times more likely to be involved in accidents on or
off the job,
* will be absent or late to work or leave early more than
twice as often as the non-user,
* will apply for sickness benefits 4-5 times more often
than the non-user,
* will exhibit a diminished (usually 33%) productivity,
* will be involved in substantially more grievance matters
and file many more worker's compensation claims.
Dr. E. Gates Morgan of the Firestone Tire & Rubber Company
Medical Department could not understand how the idea emerged that
there was such a study and he recently told a newspaper reporter
that there was no Firestone Tire & Rubber Company study. However,
these facts with little variation have been cited by Michael Walsh
who heads the NIDA Office of Workplace Initiatives in a number of
declarations in lawsuits filed by Federal Unions trying to stave
3
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off testing. They are cited by Roche Biomedical in its literature
promoting urine testing.
The uncritical citing of these documents is surprising. It
takes only a second to realize that since most workplace drug use
is secret, and we "need" to test millions to learn about it, how
could we know these imposing facts about recreational users? Since
they. are seldom caught, how could we know that they have filed five
times the number of compensation cases and are 2.2 times more
likely to be absent from work? These pumbers are made up and Dr.
Kleber's citing of these justifications for testing simply indicate
the completeness of his new affiliation to the Czar's office as
opposed to his prior affiliation to an academic ideal of
skepticism, criticism, and truth.
Proponents of testing who move beyond the repetition of
fraudulent Firestone data will often cite the Postal Study.
Although this actually exists, it does not make the case for
testing at all.
U.S. Postal Service
The U.S. Postal Service decided to conduct an evaluation of
pre-employment testing. Preliminary reports of the study indicate
that a slightly higher percentage of those testing positive had
been fired than those testing negative (15.4% versus 10.5%). The
study simply has no validity and was improperly designed. Almost
all the positives were significantly younger than the negatives.
It is well established that for first hires, the retention rate of
mature workers exceeds that of youthful workers. In fact, the Post
Office Study generated a positive group consisting almost
exclusively of youthful Black males while the "control" group
contains older, white applicants. The study does not at all
indicate that the 4-5% differences in retention in a youthful
minority group of workers from a "control" group of older non-
minority workers had anything to do with the positive marijuana
test rate. The positive marijuana use was associated with this
group of hirees who were not retained. one could as well postulate
that some other factor predominantly associated with the youthful
group caused their job loss - how about a preference for Nike
footwear or a greater mass of hair?
Compiled Testing Results
In a recent NIDA monograph, there is a report of data
generated under a California law requiring composite evaluation of
results from some California laboratories engaging in drug-abuse
urine testing. The results are somewhat skewed in the direction
of positives because the laboratories were reporting both screening
positives and later confirmations as two separate tests. Despite
this, the incidence of positives in the workplace was very low.
To quote this article:
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"The first-year results, however, raise serious questions
about the value of drug testing in the workplace. When we
consider that only 1 or 2 out of each 100 tests in the
employee population are positive and that due to the
limitations previously discussed, even those 1 or 2 positives
may represent an overstatement of the actual number of
positive tests in general, we have to decide whether we really
need to test for drugs in employee populations."
Aggressive repeated random testing in the workplace, or at
schools, or at the Republican National Convention, may deter some
casual users. I accept that, although the proof is still lacking
to confirm even this benefit. This result would constitute
preventive surveillance - exactly the sort of political solution
that has been unacceptable heretofore in a constitutional
democracy. Actually, despite the enormous cost of our testing
programs, they probably do not go far enough to accomplish even the
goal of deterrence.
Drug testing does not sanitize the workplace nor does it
enhance productivity or safety or decrease health costs. It stands
as an expensive symbolic folly which harms individual workers and
fools us. It is drug abuse abuse.
ince ely,
Jo P. Morga
Mj~d ical Professor
CUNY Medical School
JPM/mmp
